Overview: Contains only the most up-to-date, targeted, clinically relevant content to suit physicians’ needs.Expertly written by globally recognized, established key thought leaders in the cardiology field.EffeThis handbook offers timely investigation of current pharmaceutical trends, clinical guidelines, novel treatments, and ongoing pipeline developments, including ground-breaking advances in the use of novel oral anticoagulants. Atrial fibrillation (AF) affects an estimated 1–2% of the population and is the most common cause of sustained cardiac arrhythmia. Critically, the number of patien
|